Data / Research funding / College of Health Sciences, University of Ghana
College of Health Sciences, University of Ghana: 5 NIH awards ($2.1M), fiscal years 2021 to 2026
College of Health Sciences, University of Ghana in Accra is funded under 5 NIH awards ($2.1M) in the NIH and NSF award files, read 2026-11-04. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- JMP4KX9ZY7Q4UEI
Awards
5 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| H3Africa Kidney Disease Research Network- Collaborative Centers | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $1,011,450 | August 15, 2012 | August 31, 2023 | ADU, DWOMOA | reporter.nih.gov |
| Application of Data Science to Build Research Capacity in Zoonoses and Food-Borne Infections in West Africa | NIH | Fogarty International Center | 2023 to 2025 | $593,208 | September 1, 2023 | May 31, 2026 | SAMPANE-DONKOR, ERIC | reporter.nih.gov |
| Multidisciplinary sickle cell disease obstetrics care program in Ghana: Non-academic vs.Academic Hospital (Pilot Study) | NIH | Fogarty International Center | 2023 to 2025 | $255,940 | August 11, 2023 | April 30, 2028 | ASARE, EUGENIA VICKY | reporter.nih.gov |
| APOL1 and increased risk of Preeclampsia in West Africa | NIH | Fogarty International Center | 2021 to 2022 | $158,317 | September 21, 2018 | August 31, 2023 | OSAFO, CHARLOTTE | reporter.nih.gov |
| Invasive Anopheles stephensi in Ghana: Sampling Tools and Vector Population Dynamics | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $108,000 | July 1, 2024 | May 31, 2026 | AFRANE, YAW ASARE | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 3 | $337,046 | 0 | $0 |
| 2024 | 3 | $337,056 | 0 | $0 |
| 2023 | 2 | $283,046 | 0 | $0 |
| 2022 | 1 | $76,388 | 0 | $0 |
| 2021 | 2 | $1,093,379 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Global Brain and Nervous System Disorders Research Across the Lifespan - Exploratory Grants | PAR-26-144 | NIH | 93.989 | November 15, 2026 | Not listed | Same assistance listing 93.989 as 3 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.989 | November 16, 2026 | $50,000 | Same assistance listing 93.989 as 3 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.989 | November 18, 2026 | Not listed | Same assistance listing 93.989 as 3 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Required) | PAR-24-295 | NIH | 93.989 | December 3, 2026 | Not listed | Same assistance listing 93.989 as 3 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) | PAR-24-296 | NIH | 93.989 | December 3, 2026 | Not listed | Same assistance listing 93.989 as 3 awards here |
| International Research Scientist Development Award (IRSDA) | PAR-28-040 | NIH | 93.989 | February 9, 2027 | Not listed | Same assistance listing 93.989 as 3 awards here |
| Digital Health Technology and Reciprocal Innovation to Improve Clinical and Public Health Outcomes | PAR-28-039 | NIH | 93.989 | February 11, 2027 | Not listed | Same assistance listing 93.989 as 3 awards here |
| Implementation and Evaluation of Databases to Examine AIDS | RFA-AI-28-025 | NIH | 93.989 | May 27, 2027 | Not listed | Same assistance listing 93.989 as 3 awards here |
| Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth) | RFA-TW-28-001 | NIH | 93.989 | September 22, 2027 | Not listed | Same assistance listing 93.989 as 3 awards here |
| Emerging Global Leader Award (K43) | PAR-28-070 | NIH | 93.989 | October 12, 2027 | Not listed | Same assistance listing 93.989 as 3 awards here |
| Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) | PAR-25-143 | NIH | 93.989 | January 7, 2028 | Not listed | Same assistance listing 93.989 as 3 awards here |
| Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) | PAR-25-233 | NIH | 93.989 | January 7, 2028 | Not listed | Same assistance listing 93.989 as 3 awards here |
| Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) | PA-26-001 | NIH | 93.989 | November 30, 2028 | Not listed | Same assistance listing 93.989 as 3 awards here |
| NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional) | PA-26-002 | NIH | 93.989 | May 7, 2029 | Not listed | Same assistance listing 93.989 as 3 awards here |
| Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed) | PAR-28-090 | NIH | 93.989 | May 25, 2029 | Not listed | Same assistance listing 93.989 as 3 awards here |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 1 award here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 1 award here |
| Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional) | RFA-OD-27-009 | NIH | 93.310 | November 10, 2026 | Not listed | Same assistance listing 93.310 as 1 award here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.310 | November 18, 2026 | Not listed | Same assistance listing 93.310 as 1 award here |
| Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed) | RFA-RM-27-007 | NIH | 93.310 | November 23, 2026 | Not listed | Same assistance listing 93.310 as 1 award here |
Topics of its NIH awards
- Clinical Research
- Infectious Diseases
- Rare Diseases
- Genetics
- Kidney Disease
- Maternal Health
- Maternal Morbidity and Mortality
- Pediatric
- Pregnancy
- Prevention
- Hematology
- Sickle Cell Disease
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.